Search for a trial | Research with human participants

1 results

A Phase 1a/1b Open label, Multicenter, Global, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 as a Single Agent and in Combination with Atezolizumab in Patients with Locally Advanced or Metastatic Solid Tumors

Approved WMORecruiting

This study has been transitioned to CTIS with ID 2023-506285-31-00 check the CTIS register for the current data. This study will evaluate the safety, tolerability, pharmacokinetics, and activity of XmAb24306 as a single agent (Phase Ia) or in…